| Dr Thomas Alan Russo, MD, CM | |
|
3495 Bailey Ave, Buffalo, NY 14215-1129 | |
| (716) 834-9200 | |
| Not Available |
| Full Name | Dr Thomas Alan Russo |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 3495 Bailey Ave, Buffalo, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801816822 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 198067 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Alan Russo, MD, CM 3435 Main St, Brb, Room 141, Buffalo, NY 14214-3001 Ph: (716) 829-2674 | Dr Thomas Alan Russo, MD, CM 3495 Bailey Ave, Buffalo, NY 14215-1129 Ph: (716) 834-9200 |
News Archive
A new study from US reveals that hearing loss is becoming more common among young people. The study reports that 1 in 5 adolescents now have some hearing problems, particularly in perceiving high-frequency sounds. Researchers say loud music could be one of the reasons for this.
Phadia today announced that it has entered into an agreement to acquire 100 per cent of the shares in the Chinese marketing company WKL from the parent company MeiRui. The acquisition is made through AllergonAB, a wholly owned subsidiary of Phadia, and is subject to approval by Chinese authorities.
Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."
The Wall Street Journal examines how "some local social entrepreneurs are coming up with new ideas to provide the poor with access to better medical services" in Pakistan, where the health care system is "split between low-cost government-funded hospitals offering basic services and expensive private-sector medical institutions ... but the majority of the country's 190 million people have little access to health care."
The most comprehensive analysis yet of the epigenetic modifications present in breast cancer has revealed potentially important new ways to detect and treat the disease, Belgian researchers have reported.
› Verified 2 days ago
Musa Saeed, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton Streets, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-1374 | |
Dr. Reena Bose, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 899 Main St, Buffalo, NY 14203 Phone: 716-878-2700 Fax: 716-878-2701 | |
Michael S Winnicki, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: Elm And Carlton St, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-4693 | |
John Crane, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 462 Grider St, Buffalo, NY 14215 Phone: 716-829-2676 | |
Samjot S Dhillon, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton St, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-1110 | |
Bonnie Theresa Gleason, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 565 Abbott Rd, Buffalo, NY 14220 Phone: 716-560-8416 | |
Sanjivini Wadhwa, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 462 Grider St, Buffalo, NY 14215 Phone: 716-898-4119 |